The impact of functional vitamin D3 receptor conformations on DNA- dependent vitamin D3 signaling

Molecular Pharmacology

Volumn 57, Issue 2, 2000, Pages 375-384

  Quack, Marcus ^a   Carlberg, Carsten ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; COLECALCIFEROL RECEPTOR; DNA DEPENDENT PROTEIN KINASE; EB 1436; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR; VITAMIN D RECEPTOR AGONIST;

AMINO TERMINAL SEQUENCE; ARTICLE; CRYSTAL STRUCTURE; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION; VITAMIN D METABOLISM;

BINDING, COMPETITIVE; CHOLECALCIFEROL; DNA; GENE DELETION; LIGANDS; PROTEIN CONFORMATION; RECEPTORS, CALCITRIOL; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033966756     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. 3: Direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 15:5789-5799.
2. Bouillon R, Okamura WH and Norman AW (1995) Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16:200-257.
3. Bourguet W, Ruff M, Chambon P, Gronemeyer H and Moras D (1995) Crystal structure of the ligand binding domain of the human nuclear receptor RXR-α. Nature 375:377-382.
4. 3: Interplay with retinoid and thyroid hormone signalling. Eur J Biochem 231:517-527.
5. 3 receptor in the context of the nuclear receptor superfamily: The central role of retinoid X receptor. Endocrine 4:91-105.
6. Carlberg C, Bendik I, Wyss A, Meier E, Sturzenbecker LJ, Grippo JF and Hunziker W (1993) Two nuclear signalling pathways for vitamin D. Nature (Lond) 361:657-660.
7. 3. Crit Rev Eukaryot Gene Expr 8:19-42.
8. 3 analogue is related to promoter selectivity. J Cell Biochem 66:552-562.
9. 3. J Cell Biochem 63:199-206.
10. DeLuca HF, Krisinger J and Darwish H (1990) The vitamin D system. Kidney Int 38:S2-S8.
11. Fanjul A, Dawson MI, Hobbs PD, Jong L, Cameron JF, Harlev E, Graupner G, Lu X-P and Pfahl M (1994) A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature 372:107-111.
12. Freedman LP (1992) Anatomy of the steroid receptor zinc finger region. Endocr Rev 13:129-145.
13. Glass CK (1994) Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr Rev 15:391-407.
14. 3 receptor binding site found in the rat atrial natriuretic factor promoter. Biochem Biophys Res Commun 218:882-886.
15. Kissmeyer A-M, Binderup E, Binderup L, Mørk Hansen C, Rastrup Andersen N, Makin HLJ, Schroeder NJ, Shankar VN and Jones G (1997) Metabolism of the vitamin D analog EB1089: Identification of in vivo and in vitro liver metabolites and their biological activities. Biochem Pharmacol 53:1087-1097.
16. Leng X, Tsai S, O'Malley BW and Tsai M-J (1993) Ligand-dependent conformational changes in thyroid hormone and retinoic acid receptors are potentially enhanced by heterodimerization with retinoid X receptor. J Steroid Biochem Molec Biol 46:643-661.
17. 3 analogues and their 20-epi homologues with the vitamin D receptor. J Biol Chem 272:3336-3345.
18. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P and Evans RM (1995) The nuclear receptor superfamily: The second decade. Cell 83:835-839.
19. Moras D and Gronemeyer H (1998) The nuclear receptor ligand-binding domain: Structure and function. Curr Opin Cell Biol 10:384-391
20. 3 receptor. Biochem J 235:561-568.
21. 3 analogues is not related to the AP-1 pathway, but related to promoter selectivity. Oncogene 11: 1853-1858.
22. 3 receptor is functionally linked to the transactivation domain 2 (AF-2). Nucleic Acids Res 24:4513-4519.
23. 3 correlates well with gene activation. J Cell Biochem 62:325-333.
24. 3: past, present, and future. J Bone Mineral Res 13:1360-1369.
25. 3. J Cell Biochem 74:323-333.
26. 3 indicates that the 6-s-cis conformation is preferred for rapid nongenomic biological responses and that neither 6-s-cis- nor 6-s-trans-locked analogs are preferred for genomic biological responses. Mol Endocrinol 11:1518-1531.
27. 3 are associated with enhanced activation of the vitamin D receptor. J Biol Chem 270:10551-10558.
28. Quack M and Carlberg C (1999) Selective recognition of the vitamin D receptor conformations mediates promoter selectivity of vitamin D. Mol Pharmacol 55: 1077-1087.
29. Quack M, Clarin A, Binderup E, Björkling F, Mørk Hansen C and Carlberg C (1998a) Structural variants of the vitamin D analogue EB1089 reduce its ligand sensitivity and promoter selectivity. J Cell Biochem 71:450-460.
30. 3 analogue EB1089 alters receptor complex formation and reduces promoter selectivity. Br J Pharmacol 125:607-614.
31. Quack M, Szafranski K, Rouvinen J and Carlberg C (1998c) The role of the T-box for the function of the vitamin D receptor on different types of response elements. Nucleic Acids Res 26:5372-5378.
32. Renaud J-P, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H and Moras D (1995) Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid. Nature 378:681-689.
33. Väisänen S, Juntunen K, Itkonen A, Vihko P and Mäenpää PH (1997) Conformational studies of human vitamin-D receptor by antipeptide antibodies, partial proteolytic digestion and ligand binding. Eur J Biochem 248:156-162.
34. Walters MR (1992) Newly identified actions of the vitamin D endocrine system. Endocr Rev 13:719-764.
35. Wurtz J-M, Bourguet W, Renaud J-P, Vivat V, Chambon P, Moras D and Gronemeyer H (1996) A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struc Biol 3:87-94.
36. Wurtz J-M, Guillot B and Moras D (1997) 3D model of the ligand binding domain of the vitamin D nuclear receptor based on the crystal structure of holo RARγ, in Proceedings of the 10th International Vitamin D Workshop (Norman AW, Bouillon R and Thomasset M eds) pp 165-172, Printing and Reprogragraphics, Riverside.
37. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, Kawakami T, Airoka K, Sato H, Uchiyama Y, Masushige S, Fukamizu A, Matsumoto T and Kato S (1997) Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 16:391-396.